GSK/Medicago COVID-19 Vaccine Looks Like Also-Ran But Antibody Shows Value Against Omicron

Sotrovimab’s Sustained Efficacy Confirmed

 
• By Andrew McConaghie
  
Vir Biotechnology offices San Francisco
GSK's alliance with San Francisco-based Vir could become its most successful COVID-19 partnership • Source: Alamy

More from Business

More from Scrip